Patients
17.6 % of people
People aged 65 and over, New Zealand, 2025 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
New Zealand Spinal Implants Market Industry Trends and Forecast to 2034: Segmented by (Product, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$87.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $136.8 Mn | — | — |
| 2025 (base) | $144.2 Mn | +$7.4 Mn | — |
| 2026 (forecast) | $152.0 Mn | +$7.8 Mn | +5.4% |
| 2027 (forecast) | $160.2 Mn | +$8.2 Mn | +11.1% |
| 2028 (forecast) | $168.8 Mn | +$8.7 Mn | +17.1% |
| 2029 (forecast) | $178.0 Mn | +$9.1 Mn | +23.4% |
| 2030 (forecast) | $187.6 Mn | +$9.6 Mn | +30.1% |
| 2031 (forecast) | $197.7 Mn | +$10.1 Mn | +37.1% |
| 2032 (forecast) | $208.4 Mn | +$10.7 Mn | +44.5% |
| 2033 (forecast) | $219.6 Mn | +$11.3 Mn | +52.3% |
| 2034 (forecast) | $231.5 Mn | +$11.9 Mn | +60.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $144.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $231.5 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, procedure and end user (see all) |
| Key players | Medtronic, Globus Medical, Inc., Johnson & Johnson, Stryker, Zimmer Biomet Holdings, Inc. (see all) |
| Regulator in New Zealand | Medsafe (WAND)Source: Medsafe. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Spinal implants such as screws, rods, cages and artificial discs stabilise or replace parts of the spine.
Key segments of the spinal Implants market include product (Fusion Devices, Non-Fusion Devices and Biologics) and procedure (Open Surgery and Minimally Invasive).
An ageing and more active population, more sports injuries, rising obesity and better implants and procedures are driving the spinal Implants market.
Same-day joint surgery, robotics, smart implants and biologic treatments give the spinal Implants market room to grow.
High procedure costs, pricing pressure from hospitals, recalls and long recovery times hold back the spinal Implants market.
The spinal Implants market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.[1] Pharmac decides which medicines and medical devices the public health system pays for.[2] People aged 65 and over: 17.6% of people in 2025, the latest World Bank figure for New Zealand.[3]
[1] Medsafe. Checked 14 Nov 2026.
[2] Pharmac. Checked 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how spinal Implants products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.
What doctors and scientists are doing in Spinal Implants right now, from free public sources.
17.6 % of people
People aged 65 and over, New Zealand, 2025 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 17 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
From our blog
New Zealand · 1 shared keyword
New Zealand · 1 shared keyword
New Zealand
New Zealand
New Zealand
New Zealand
Digital Health · New Zealand
Pharmaceuticals · New Zealand
Pharmaceuticals · New Zealand
OTC & Nutraceuticals · New Zealand
Healthcare Services · New Zealand
Pharmaceuticals · New Zealand